v3.25.2
Condensed Consolidated Statements of Convertible Preferred Stock, Redeemable Noncontrolling Interest and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Class A and Class B Common Stock
Common Class A And B
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Jan. 31, 2024 $ 192        
Noncontrolling Interest [Roll Forward]          
Net income (loss) attributable to redeemable non-controlling interest (216)        
Ending balance at Jul. 31, 2024 (24)        
Beginning balance (in shares) at Jan. 31, 2024   100,210,000      
Beginning balance at Jan. 31, 2024 444,233 $ 10 $ 928,494 $ (483,093) $ (1,178)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for options exercised (in shares)   401,000      
Issuance of common stock for options exercised 2,205   2,205    
Issuance of common stock under employee stock purchase plan (in shares)   149,000      
Issuance of common stock under employee stock purchase plan 4,752   4,752    
Vesting of restricted stock units (in shares)   1,165,000      
Stock-based compensation 58,871   58,871    
Other comprehensive income 925       925
Charitable donation of stock (in shares)   32,000      
Charitable donation of stock 1,347   1,347    
Net Income (Loss) (58,640)     (58,640)  
Ending balance at Jul. 31, 2024 453,693 $ 10 995,669 (541,733) (253)
Ending balance (in shares) at Jul. 31, 2024   101,957,000      
Beginning balance at Apr. 30, 2024 126        
Noncontrolling Interest [Roll Forward]          
Net income (loss) attributable to redeemable non-controlling interest (150)        
Ending balance at Jul. 31, 2024 (24)        
Beginning balance (in shares) at Apr. 30, 2024   101,020,000      
Beginning balance at Apr. 30, 2024 436,107 $ 10 958,224 (518,734) (3,393)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for options exercised (in shares)   168,000      
Issuance of common stock for options exercised 1,170   1,170    
Issuance of common stock under employee stock purchase plan (in shares)   149,000      
Issuance of common stock under employee stock purchase plan 4,752   4,752    
Vesting of restricted stock units (in shares)   588,000      
Stock-based compensation 30,176   30,176    
Other comprehensive income 3,140       3,140
Charitable donation of stock (in shares)   32,000      
Charitable donation of stock 1,347   1,347    
Net Income (Loss) (22,999)     (22,999)  
Ending balance at Jul. 31, 2024 453,693 $ 10 995,669 (541,733) (253)
Ending balance (in shares) at Jul. 31, 2024   101,957,000      
Beginning balance at Jan. 31, 2025 (112)        
Noncontrolling Interest [Roll Forward]          
Net income (loss) attributable to redeemable non-controlling interest 281        
Ending balance at Jul. 31, 2025 169        
Beginning balance (in shares) at Jan. 31, 2025   103,951,000      
Beginning balance at Jan. 31, 2025 474,861 $ 10 1,062,613 (586,836) (926)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for options exercised (in shares)   940,000      
Issuance of common stock for options exercised 3,201   3,201    
Issuance of common stock under employee stock purchase plan (in shares)   196,000      
Issuance of common stock under employee stock purchase plan 4,882   4,882    
Vesting of restricted stock units (in shares)   1,378,000      
Stock-based compensation 68,245   68,245    
Other comprehensive income 822       822
Charitable donation of stock (in shares)   48,000      
Charitable donation of stock 1,860   1,860    
Net Income (Loss) (63,685)     (63,685)  
Issuance of common stock from acquisition (in shares)   2,019,000      
Issuance of common stock from acquisition 73,402 $ 1 73,401    
Replacement share-based awards issued in connection with acquisition 35,293   35,293    
Ending balance at Jul. 31, 2025 598,881 $ 11 1,249,495 (650,521) (104)
Ending balance (in shares) at Jul. 31, 2025   108,532,000      
Beginning balance at Apr. 30, 2025 33        
Noncontrolling Interest [Roll Forward]          
Net income (loss) attributable to redeemable non-controlling interest 136        
Ending balance at Jul. 31, 2025 169        
Beginning balance (in shares) at Apr. 30, 2025   104,867,000      
Beginning balance at Apr. 30, 2025 474,426 $ 10 1,095,070 (622,622) 1,968
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for options exercised (in shares)   689,000      
Issuance of common stock for options exercised 2,596   2,596    
Issuance of common stock under employee stock purchase plan (in shares)   196,000      
Issuance of common stock under employee stock purchase plan 4,882   4,882    
Vesting of restricted stock units (in shares)   737,000      
Stock-based compensation 37,502   37,502    
Other comprehensive income (2,072)       (2,072)
Charitable donation of stock (in shares)   24,000      
Charitable donation of stock 751   751    
Net Income (Loss) (27,899)     (27,899)  
Issuance of common stock from acquisition (in shares)   2,019,000      
Issuance of common stock from acquisition 73,402 $ 1 73,401    
Replacement share-based awards issued in connection with acquisition 35,293   35,293    
Ending balance at Jul. 31, 2025 $ 598,881 $ 11 $ 1,249,495 $ (650,521) $ (104)
Ending balance (in shares) at Jul. 31, 2025   108,532,000